PedAM
Pediatric Disease Annotations & Medicines
| Disease | heart disease |
| Phenotype | C0011860|type 2 diabetes |
| Sentences | 46 |
| PubMedID- 23496967 | Low-molecular-weight lipoprotein (a) and low relative lymphocyte concentration are significant and independent risk factors for coronary heart disease in patients with type 2 diabetes mellitus: lp(a) phenotype, lymphocyte, and coronary heart disease. |
| PubMedID- 23155698 | Association analysis between endothelial function related factors and coronary artery stenosis degree in coronary heart disease patients with type 2 diabetes mellitus. |
| PubMedID- 22031479 | We questioned whether gender influences the albuminuria-ischemic heart disease relationship in patients with type 2 diabetes. |
| PubMedID- 22039842 | Association between apolipoprotein e-polymorphism and ischemic heart disease patients with or without type 2 diabetes mellitus: a preliminary study in kuwait. |
| PubMedID- 24809916 | Thyroid stimulating hormone levels and risk of coronary heart disease in patients with type 2 diabetes mellitus. |
| PubMedID- 20922871 | [hypoglycemic therapy in heart disease patients with type 2 diabetes mellitus]. |
| PubMedID- 21771973 | Total soluble and endogenous secretory receptor for advanced glycation end products as predictive biomarkers of coronary heart disease risk in patients with type 2 diabetes: an analysis from the cards trial. |
| PubMedID- 23029739 | Secondary prevention therapies for coronary heart disease in patients with type 2 diabetes: an audit. |
| PubMedID- 23030294 | Coronary heart disease in type 2 diabetes: mechanisms and comprehensive prevention strategies. |
| PubMedID- 26190179 | Background: type 2 diabetes (dmt2) combined with ischemic heart disease (ihd) promotes the occurrence and development of coronary atherosclerosis. |
| PubMedID- 25539716 | Adiposity markers and risk of coronary heart disease in patients with type 2 diabetes mellitus. |
| PubMedID- 22629043 | A 58 year old male, a known case of ischaemic heart disease with type 2 diabetes mellitus and hypertension, who had been admitted for cerebellar stroke 2 months back, came with complaints of dry cough- (more at night), gradually increasing breathlessness (new york heart association, nyha grade-i to start with and displaying gradual progression to nyha grade iv in a period of 3 days), and swelling all over the body with minimal abdominal distension. |
| PubMedID- 26222704 | The michigan model for coronary heart disease in type 2 diabetes: development and validation. |
| PubMedID- 22022235 | [34] report an interaction of 9p21 and glycosylated hemoglobin, a marker of hyperglycemia, on coronary heart disease in individuals with type 2 diabetes. |
| PubMedID- 25849783 | Myocardial triglyceride accumulation is an early sign of heart disease in type 2 diabetes and is associated with changes in cardiac function, in particular diastolic dysfunction [16,39,40]. |
| PubMedID- 23774274 | Ldl-cholesterol versus non-hdl-to-hdl-cholesterol ratio and risk for coronary heart disease in type 2 diabetes. |
| PubMedID- 22442750 | Aim: to analyze the risk of coronary heart disease in patients with type 2 diabetes mellitus (t2dm) receiving standard medical treatment. |
| PubMedID- 22152955 | Genetic susceptibility to coronary heart disease in type 2 diabetes: 3 independent studies. |
| PubMedID- 24933031 | Accumulation of oxidative stress-related gene polymorphisms and the risk of coronary heart disease events in patients with type 2 diabetes--an 8-year prospective study. |
| PubMedID- 25088437 | Background: hyperglycaemia could substantially increase the risk of ischaemic heart disease in patients with type 2 diabetes. |
| PubMedID- 24083205 | Hence, an open label, prospective, randomized, parallel study was undertaken to investigate the hypothesis that combination therapy with atorvastatin and fenofibrate will be more effective than monotherapy with a statin/fibrate to prevent coronary heart disease in patients with type 2 diabetes mellitus. |
| PubMedID- 26531321 | Fasting hyperinsulinaemia and 2-h glycaemia predict coronary heart disease in patients with type 2 diabetes. |
| PubMedID- 21736547 | Such risk reduction for coronary heart disease events in patients with type 2 diabetes was not observed by improved glycemic control achieved by intensified treatment with insulin and glibenclamid [138]. |
| PubMedID- 26385042 | Assessment of serum 25-hydroxy vitamin d improves coronary heart disease risk stratification in patients with type 2 diabetes. |
| PubMedID- PMC3837026 | Association between a genetic variant related to glutamic acid metabolism and coronary heart disease in individuals with type 2 diabetes. |
| PubMedID- 24373412 | Moreover, the prevalence of coronary heart disease in patients with type 2 diabetes was found to be significantly higher in patients with cca-imt ≥ 1.1 mm than < 1.1 mm[9]. |
| PubMedID- 22776317 | Evaluation of risk equations for prediction of short-term coronary heart disease events in patients with long-standing type 2 diabetes: the translating research into action for diabetes (triad) study. |
| PubMedID- 21499988 | It is estimated that in the next 10 years, the majority of all heart disease will be associated with type 2 diabetes mellitus [63]. |
| PubMedID- 23220502 | Methods: a total of 132 type 2 diabetes mellitus without coronary heart disease (t2dm) cases and 135 type 2 diabetes mellitus with coronary heart disease (t2dm+chd) cases received intensive glycemic control. |
| PubMedID- 23644116 | Conclusion: aldh2 gene g487a polymorphism may be associated with hypertension in patients with coronary heart disease complicated by type 2 diabetes, and the patients with an a allele have a greater risk of developing hypertension. |
| PubMedID- 23320535 | In a study on mortality due to coronary heart disease associated with type 2 diabetes in iceland over the period 1967–1991, the relative risk of death at a mean age of 55 years was found to be 2.0 for men and 2.4 for women, compared to those without diabetes [13]. |
| PubMedID- 22021872 | Asymptomatic coronary heart disease in patients with type 2 diabetes with vascular complications: a cross-sectional study. |
| PubMedID- 22815299 | In separate univariate cox regression models, age, living in a nursing home, type 2 diabetes, history of coronary heart disease, history of stroke, cri, dialysis, and pad were significant risk increasing factors, the presence of charcot foot syndrome a significant preventive factor (table 3). |
| PubMedID- 24199170 | Diabetic retinopathy is also associated with intima media thickness and arterial stiffness [6] and predicts coronary heart disease events in patients with type 2 diabetes [7]. |
| PubMedID- 26003803 | Metabolic disorders such as dyslipidemia are observed in the majority of t2dm patients and represents an independent risk factor for the development of coronary heart disease in people with type 2 diabetes [34]. |
| PubMedID- 22752054 | These findings are in agreement with three studies that have reported positive associations of hmgb1 with coronary artery disease [3, 4], heart failure [5] and mortality related to heart disease [5] in patients with and without type 2 diabetes, though these were limited by their cross-sectional study design [3–5] or short follow-up period [5]. |
| PubMedID- 24602408 | Investigated the relationship of srage to incident coronary heart disease (chd) in patients with type 2 diabetes [28]. |
| PubMedID- 21833536 | Effects of the pparg p12a and c161t gene variants on serum lipids in coronary heart disease patients with and without type 2 diabetes. |
| PubMedID- 21883434 | Time trends in absolute and modifiable coronary heart disease risk in patients with type 2 diabetes in the swedish national diabetes register (ndr) 2003-2008. |
| PubMedID- 21371992 | The formula predicts occurrence of new heart disease in people with type 2 diabetes and incorporates hemoglobin a1c, systolic blood pressure, and lipid levels along with age, sex, race, smoking status, and time since diabetes diagnosis [37]. |
| PubMedID- 23982368 | Association between a genetic variant related to glutamic acid metabolism and coronary heart disease in individuals with type 2 diabetes. |
| PubMedID- 23915379 | Described that lp-pla2 activity was associated with incident coronary heart disease in patients with type 2 diabetes [29], but nelson et al. |
| PubMedID- 20929988 | Patients were told that the study was designed to help improve medication therapy for heart disease risk in patients with type 2 diabetes. |
| PubMedID- 25454625 | Objective: to analyze the level of creatine kinase isoenzyme (ckmb), myoglobin, to explore the influence of different glucose-lowering rate on cardiac enzyme in type 2 diabetes mellitus patients with coronary heart disease (t2dmc), to search for the rational glucose-lowering rate. |
| PubMedID- 20040882 | Purpose: the cardiovascular disease risk profile and exercise capacity of coronary heart disease patients with type 2 diabetes mellitus (dm) were measured and compared with those of nondiabetic (ndm) patients before and after a 6-week multidisciplinary cardiac rehabilitation program. |
| PubMedID- 26385228 | Methods: this randomized, double-blind, placebo-controlled trial was performed among 60 overweight or obese and type 2 diabetes mellitus patients with coronary heart disease aged 40-85 years old. |
Page: 1